Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BIO-013077-01
Cat. No.:
OB0225LY-0211
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
BIO-013077-01 is a small molecule compound with potential biological activity designed to influence intracellular signaling pathways.
Synonym:
746667-48-1; 6-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)quinoxaline; 6-[5-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl]quinoxaline; Quinoxaline, 6-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-
CAS No.:
746667-48-1
Compound CID:
10469294
Formula:
C17H13N5
Formula Weight:
287.32
Specification
Relative Density:
1.296 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
BIO-013077-01 can be used for cell signaling research and drug discovery.
Library Information
Targets:
TGF-β receptor family
Pathways:
Stem cells; TGF-beta/Smad signaling
Plate Number:
AOCL-3
Plate Location:
f5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
10 mg/mL; 34.8 mM
